Search results
Moderna Tumbles After The FDA Throws A Curveball On Its Second Product
Investor's Business Daily· 15 minutes ago"Although regulatory delays are disappointing and usually create noise around the probability of...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 9 hours agoThe FDA has informed Moderna that it is working to conclude...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via Yahoo News· 9 hours agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...
Moderna says FDA will not complete review of RSV vaccine by May 12 deadline
Market Watch· 9 hours agoThe FDA cited administrative constraints for the delay, Cambridge, Mass.-based Moderna said in a...
FDA delays decision on Moderna RSV vaccine
BioPharma Dive via Yahoo Finance· 9 hours agoThe regulator cited “administrative constraints,” rather than any issue with Moderna’s trial data, for missing a May 12 deadline, the company said.
Moderna says FDA delayed RSV vaccine approval to end of May
CNBC· 9 hours agovaccine for respiratory syncytial virus to the end of May due to "administrative constraints" at the...
Moderna Says FDA Delaying Decision on RSV Vaccine Approval
Bloomberg· 9 hours agoHave a confidential tip for our reporters? US regulators’ decision on whether to approve Moderna...
Moderna says FDA delaying decision on RSV vaccine approval, shares fall By Investing.com
Investing.com· 7 hours agoModerna (NASDAQ:MRNA) shares are down just over 1% in early Friday trading after the company said...
AstraZeneca pulls Covid vaccine after admitting rare side effect
Daily Express· 3 days agoThe Oxford-AstraZeneca Covid vaccine is set to be withdrawn after the pharmaceutical giant admitted...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 1 day ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
